Literature DB >> 15816439

Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth.

Seikan Hai1, Shoji Kubo, Takahiro Uenishi, Takatsugu Yamamoto, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Kazuhiro Hirohashi.   

Abstract

Clinicopathologic variables favoring recurrence after hepatic resection for intrahepatic cholangiocarcinoma showing intraductal growth remain unclear. We investigated various clinicopathologic features in three patients who underwent resection for this type of intrahepatic cholangiocarcinoma. All underwent extended left hepatectomy plus resection of the caudate lobe and lymph node dissection. Lymph nodes showed no pathologic involvement. Although no cancer cells were seen in the mucosal layer by intraoperative pathologic examination at the bile duct stump in any patient, pathologic examination of resected specimens showed cancer cells invading beyond the mucosal layer in connective tissues surrounding the bile duct stump (interstitial invasion) of the Glisson's sheath in 2 patients. One of them died of cancer recurrence near the bile duct stump, while the third patient, without interstitial invasion, has survived for 10.6 years. In the intraductal growth type of intrahepatic cholangiocarcinoma, absence of cancer cells should be confirmed by intraoperative pathologic examination of not only the mucosal layer of the bile duct but also the connective tissue surrounding the bile duct, since interstitial invasion may be a risk factor for cancer recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15816439

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells.

Authors:  Tae Won Kwak; Su Bum Park; Hyun-Jung Kim; Young-Il Jeong; Dae Hwan Kang
Journal:  Onco Targets Ther       Date:  2016-12-22       Impact factor: 4.147

2.  Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy.

Authors:  Massimo Malago; Andrea Frilling; Jun Li; Hauke Lang; Christoph E Broelsch
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.